PMID- 31852876
OWN - NLM
STAT- MEDLINE
DCOM- 20200817
LR  - 20200817
IS  - 1882-0654 (Electronic)
IS  - 0009-918X (Linking)
VI  - 60
IP  - 1
DP  - 2020 Jan 30
TI  - [A case of anti-myelin oligodendrocyte glycoprotein (MOG) antibody-related 
      disease with human leukocyte antigen (HLA) positivity indicative of neuro-Sweet 
      disease].
PG  - 51-56
LID - 10.5692/clinicalneurol.cn-001360 [doi]
AB  - A 73-year-old man with a 5-day history of continuous hiccup, fever, and rapidly 
      progressing paraplegia was admitted to our hospital. On admission, he exhibited 
      dysarthria, complete paraplegia, and insentience of both lower limbs. Head and 
      spine MRI showed abnormal, asymmetric lesions in the white matter, basal ganglia, 
      and brainstem, and multiple spinal cord lesions. Test for serum anti-AQP4 
      antibody was negative. Evaluation of human leukocyte antigen (HLA)-B51 was 
      negative; however, HLA-B54 was positive. Although skin lesions were absent, we 
      considered neuro-Sweet disease and high-dose steroid therapy was initiated. The 
      hiccup disappeared gradually, and he regained the ability to walk with a cane 30 
      days after the onset. Subsequently, the patient tested positive for serum 
      anti-myelin oligodendrocyte glycoprotein (MOG) antibody. It is important to 
      consider MOG antibody-related disease as potential diagnosis in patients 
      exhibiting clinical features of neuro-Sweet disease except for the absence of 
      skin lesions.
FAU - Takeuchi, Yosuke
AU  - Takeuchi Y
AD  - Department of Neurology, National Hospital Organization Kumamoto Medical Center.
AD  - Department of Neurology, National Hospital Organization Kumamotominami National 
      Hospital.
FAU - Kouzaki, Yanosuke
AU  - Kouzaki Y
AD  - Department of Neurology, National Hospital Organization Kumamoto Medical Center.
LA  - jpn
PT  - Case Reports
PT  - Journal Article
DEP - 20191217
PL  - Japan
TA  - Rinsho Shinkeigaku
JT  - Rinsho shinkeigaku = Clinical neurology
JID - 0417466
RN  - 0 (Antibodies)
RN  - 0 (Biomarkers)
RN  - 0 (HLA Antigens)
RN  - 0 (Myelin-Oligodendrocyte Glycoprotein)
RN  - 9PHQ9Y1OLM (Prednisolone)
RN  - X4W7ZR7023 (Methylprednisolone)
SB  - IM
MH  - Aged
MH  - Antibodies/*blood
MH  - Biomarkers/blood
MH  - Central Nervous System/diagnostic imaging
MH  - *HLA Antigens
MH  - *Histocompatibility Testing
MH  - Humans
MH  - Male
MH  - Methylprednisolone/administration & dosage
MH  - Myelin-Oligodendrocyte Glycoprotein/*immunology
MH  - Prednisolone/administration & dosage
MH  - Pulse Therapy, Drug
MH  - Sweet Syndrome/*diagnosis/drug therapy
OTO - NOTNLM
OT  - anti-myelin oligodendrocyte glycoprotein antibody-related disease
OT  - hiccup
OT  - human leukocyte antigen typing
OT  - neuro-Sweet disease
OT  - syndrome of inappropriate antidiuretic hormone secretion
EDAT- 2019/12/20 06:00
MHDA- 2020/08/18 06:00
CRDT- 2019/12/20 06:00
PHST- 2019/12/20 06:00 [pubmed]
PHST- 2020/08/18 06:00 [medline]
PHST- 2019/12/20 06:00 [entrez]
AID - 10.5692/clinicalneurol.cn-001360 [doi]
PST - ppublish
SO  - Rinsho Shinkeigaku. 2020 Jan 30;60(1):51-56. doi: 
      10.5692/clinicalneurol.cn-001360. Epub 2019 Dec 17.